Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

SAB Biotherapeutics, Inc.

2.98
-0.0800-2.61%
Post-market: 3.000.0200+0.67%19:30 EDT
Volume:416.32K
Turnover:1.25M
Market Cap:271.14M
PE:-1.91
High:3.12
Open:3.10
Low:2.96
Close:3.06
52wk High:5.15
52wk Low:1.97
Shares:90.99M
Float Shares:62.04M
Volume Ratio:0.41
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5562
EPS(LYR):-0.7944
ROE:-11.27%
ROA:-33.46%
PB:1.26
PE(LYR):-3.75

Loading ...

OverviewCompanyNewsFilings

Emergent BioSolutions Inc - Executed Agreement Is Valued at Approximately $50 Mln

THOMSON REUTERS
·
Apr 29

Emergent BioSolutions: Under Terms, Co to Provide End-to-End Development, Manufacturing Services to SAB Bio

THOMSON REUTERS
·
Apr 29

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Roche Holding (OtherRHHBY), Praxis Precision Medicines (PRAX) and SAB Biotherapeutics (SABS)

TIPRANKS
·
Apr 24

Buy Rating on SABS Driven by SAB-142’s Differentiated T1D Mechanism, Durable C‑Peptide Preservation, and Pivotal SAFEGUARD Catalyst

TIPRANKS
·
Apr 23

SAB BIO says Phase 1 SAB-142 trial preserves C-peptide in adult type 1 diabetes

Reuters
·
Apr 22

SAB Bio Presents Additional Clinical and Mechanistic Data From SAB-142 Phase 1 Trial in Adult Patients With Established Autoimmune Type 1 Diabetes at Ids 2026

THOMSON REUTERS
·
Apr 22

SAB Biotherapeutics says SAFEGUARD trial of SAB-142 in type 1 diabetes enrolls patients

Reuters
·
Apr 15

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 06, 2026 Pre-MKt
Financial Report Announcement
May 12, 2026 Pre-MKt
Financial Report Announcement
Mar 09, 2026 Post-Mkt
Financial Report Announcement
Nov 13, 2025 Post-Mkt
Financial Report Announcement
Aug 07, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

-1.91
Current
-24.94
Sector Average
7.75%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.91
Maximum
160.08
+1 STD
122.96
Minimum
-759.98
-1 STD
-172.83
Average
-24.94

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.